Marvell

Posted on | by Leon Hinde | Leave a Comment on Marvell

Maravai Lifesciences Holdings Inc Cl has experienced a sharp pullback, dropping roughly 35% to 40% from its record high near $316 in early June to around $180–$195. This decline is largely attributable to valuation compression, semiconductor sector-wide momentum unwinding.

In early June, MRVL surged following high-profile commentary at Computex (where Nvidia CEO Jensen Huang called Marvell the “next trillion-dollar company”) and its inclusion in the S&P 500. This drove the stock past $315. At its peak, MRVL traded at a forward P/E exceeding 65x–70x earnings

Marvell’s upcoming Fiscal Q2 earnings report (scheduled for late August 2026) will be critical. Consensus estimates project Q2 revenue of ~$2.7 billion (+35% YoY)

Applied Optoelectronics

Posted on | by Leon Hinde | Leave a Comment on Applied Optoelectronics

Applied Optoelectronics, commenced construction on a nearly 400,000-square-foot expansion in Pearland, Texas, to support volume production of its 800G and 1.6T optical transceivers for AI datacenters.

Sector Rotation out of Crowded AI Infrastructure Trades

  • Capex Sustainability Concerns: Concerns over hyperscaler capital expenditure returns (highlighted by heavy capex outlays across big-tech AI buyers) triggered widespread profit-taking across crowded AI component trades.
  • Peer De-rating: Peers like Lumentum (LITE) and Coherent (COHR) also faced steep pullbacks as high-multiple optical names were sold off in favor of cash-generative value trades.

scheduled to release its Q2 2026 financial results on Thursday, August 6, 2026, after Market Close.

    Wall Street Expectations

    • Revenue Guidance / Estimates: Management guided Q2 revenue in the range of $180.0M – $198.0M.
    • EPS Estimate: Consensus estimates project Non-GAAP EPS around -$0.03 to +$0.03 per share.